文献速递免疫规划传染病防控与疫情报告

两种四价表位DNA疫苗诱导的免疫应答差异

Differential immune responses elicited by two tetravalent epitope-based DNA vaccines differently designed for human hand-foot-and-mouth disease.
PubMed 文献 · Vaccine · 2026-06-13

本研究在小鼠模型中评估两种四价手足口病DNA疫苗的免疫原性:EVCVAme含四种肠道病毒的B细胞表位串,VP1EVCVAme含全长EV71 VP1融合表位串。两者均诱导特异性抗体,但IgG低于既往四价疫苗pVAX1.VP1me;仅含全长VP1的疫苗诱导可检测的CD8 T细胞应答。pVAX1.EVCVAme抗体覆盖全部四种病毒。

要点

  • 两种四价DNA疫苗均诱导手足口病特异性抗体,但IgG水平低于既往pVAX1.VP1me。
  • 仅含全长VP1的疫苗诱导可检测的肠道病毒特异性CD8 T细胞应答。
  • pVAX1.EVCVAme诱导的抗体覆盖EV71、CVA16、CVA10和CVA6四种病毒。

核心结论

  • 两种四价表位DNA疫苗均具免疫原性,但抗体水平低于既往四价疫苗pVAX1.VP1me。
  • 仅含全长VP1的疫苗可诱导可检测的肠道病毒特异性CD8 T细胞应答。
  • pVAX1.EVCVAme诱导的抗体覆盖全部四种主要肠道病毒。

研究设计与样本

  • 研究在小鼠模型中开发并评估两种不同设计的四价DNA手足口病疫苗的免疫原性。
  • EVCVAme由四种肠道病毒已报道的B细胞表位串设计,VP1EVCVAme由全长EV71 VP1融合四种肠道病毒B细胞表位串设计。

主要发现

  • 两种DNA疫苗免疫小鼠均诱导手足口病特异性抗体应答,但IgG水平低于既往四价疫苗pVAX1.VP1me免疫。
  • 仅含全长VP1的疫苗诱导可检测的肠道病毒特异性CD8 T细胞应答。
  • 细胞内细胞因子染色显示,B细胞表位肽混合物再刺激后疫苗激活的CD8 T细胞呈多功能性,提示B细胞表位具有双重作用。
  • 两种疫苗联合接种未改善免疫应答的广度或强度。
  • B细胞表位作图显示各疫苗组应答表位模式不同。

关键数值与推荐

  • 两种疫苗免疫小鼠均诱导手足口病特异性抗体应答,但IgG水平低于pVAX1.VP1me免疫组。
  • 仅含全长VP1的疫苗组可检测到肠道病毒特异性CD8 T细胞应答。
  • pVAX1.EVCVAme诱导的抗体覆盖EV71、CVA16、CVA10和CVA6四种肠道病毒。
  • 两种疫苗联合接种未改善免疫应答的广度或强度。

临床怎么用

  • 为下一代四价手足口病疫苗设计提供参考:全长VP1对诱导CD8 T细胞应答可能重要。
  • B细胞表位可兼顾诱导体液免疫与细胞免疫的双重作用。
  • 联合接种两种疫苗未显示免疫增强益处。

局限性

  • 研究仅在小鼠模型中进行,尚未在人体验证。
  • 两种新疫苗诱导的IgG水平低于既往四价疫苗pVAX1.VP1me。
  • 两种疫苗联合接种未改善免疫应答广度或强度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hand-foot-and-mouth disease (HFMD) remains a significant public health concern for children. Enterovirus A71 (EV71) and coxsackievirus A16 (CVA16) have been the main causes of HFMD; however, CVA10 and CVA6 have become more prevalent in recent years. A universally effective vaccine that covers all four major enteroviruses is of importance. In this study, we developed and assessed the immunogenicity of two differently designed tetravalent DNA-based HFMD vaccines in a murine model. The new immunogen, EVCVAme, was designed with a string of reported B-cell epitopes from the four enteroviruses, while VP1EVCVAme was designed with the full-length EV71 VP1 fused with a string of reported B-cell epitopes from the four enteroviruses. In silico analysis indicated favorable structural and functional features of both immunogens. The immunization of mice with DNA vaccines expressing those two immunogens elicited HFMD-specific antibody responses, but the IgG levels were lower compared to the immunization with our previous tetravalent vaccine pVAX1.VP1me. Interestingly, only the vaccines containing full-length VP1 elicited detectable enterovirus-specific CD8 T cell response. Intracellular cytokine staining revealed polyfunctional vaccine-activated CD8 T cells upon restimulation with mixtures of the B-cell epitope peptides, indicating a dual role of these B-cell epitopes. Notably, co-administration of two vaccines neither improved the breadth nor magnitude of the immune responses. B-cell epitope mapping revealed different patterns of responding epitopes across the vaccine groups. Importantly, pVAX1.EVCVAme elicited antibodies that cover all four enteroviruses. This study offers valuable insights and important information for the improved design of a next-generation tetravalent vaccine for HFMD.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bello AM, Chaimongkolnukul K, Poomputsa K, et al. Differential immune responses elicited by two tetravalent epitope-based DNA vaccines differently designed for human hand-foot-and-mouth disease. Vaccine. 2026. PMID: 42287823. doi:10.1016/j.vaccine.2026.128824

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。